Bumetanide and Prolensa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Prolensa (bromfenac sodium). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Prolensa. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Prolensa?

Prolensa has active ingredients of bromfenac sodium. eHealthMe is studying from 1,170 Prolensa users. Check the latest studies of Prolensa.

On Jul, 17, 2026

12 people who take Bumetanide and Prolensa together, and have interactions are studied.

Bumetanide and Prolensa drug interactions.

What are the common drug interactions of Bumetanide and Prolensa, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Gastric ulcer (stomach ulcer)
Suicidal ideation
Renal injury (kidney injury)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
Renal disorder (kidney disease)
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Dry eye (lack of adequate tears)
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)

What are the common drug interactions of Bumetanide and Prolensa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal injury (kidney injury)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal disorder (kidney disease)
Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chronic kidney disease
Renal failure (kidney dysfunction)
Gastric ulcer (stomach ulcer)
Suicidal ideation

60+:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal disorder (kidney disease)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 66.67%
Pain: 7 people, 58.33%
Stress And Anxiety: 7 people, 58.33%
Depression: 7 people, 58.33%
Gastric Ulcer (stomach ulcer): 6 people, 50.00%
High Blood Cholesterol: 6 people, 50.00%
High Blood Pressure: 6 people, 50.00%
Stable Angina (a constant chest pain): 6 people, 50.00%
Diabetes: 6 people, 50.00%
Inflammation: 6 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Prolensa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously